Open AccessA Single Institution's Experience with Cytogenetic and MRD Outcomes in Pediatric Acute Lymphoblastic Leukemia
Author(s) -
Asim Amjad,
Rabia Wali,
Sadia Anjum,
Raheela Mansoor
Publication year - 2019
Publication title -
jcpsp
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 33
eISSN - 1681-7168
pISSN - 1022-386X
DOI - 10.29271/jcpsp.2019.06.549
Subject(s) - medicine , regimen , minimal residual disease , lymphoblastic leukemia , pediatrics , leukemia , cancer
To determine the frequency of cytogenetic type and its significance in the prognostic outcome of the pediatric patients in acute lymphoblastic leukemia (ALL), aged 1 to 15 years, and also determine the importance of minimal residual disease (MRD) in the management of the condition.